Grupo Lonvida is a company focused on changing the direction of Health with the creation of Wellness and Longevity Centers which combine the use of artificial intelligence (AI), genetics and regenerative medicine to help live more, better and with purpose. Grupo Lonvida is a national and foreign private investment company consolidated by a group of entrepreneurs with extensive experience in firms such as: Canyon Ranch, Uber Eats, Disney and Aeromexico, to mention some
According to the Global Wellness Institute, the Global welfare Economy reached a value of 6.32 billion dollars (USD) in 2023with projections that estimate growth up to 6.8 billion in 2024 and near 9 billion for 2028which would represent approximately 6.8% of world GDP.
In Mexico, the well -being industry also shows an upward trend. It is estimated that at the end of 2023, the size of this industry reached 27.7 billion USDwith projections that indicate an annual growth of 10.7% to 2024 and an increase to 13.3% for the 2025-2030 period, in detail preventive medicine in public health 534 billion USD, according to the National Institute of Statistics and Geography (INEGI).
This year Lonvida Group decides to invest in Mexico by opening the first of several Wellness and Longevity Center con IA as a plan of its expansion in the territory. Marking a before and after in the health sector in Mexico and Latam and with a unique proposal, Lonvida Grupo redefines traditional medical care by focusing on proactive health and personalized medicine, combining avant -garde science, precision technology and a comprehensive approach to well -being. The new center will open its doors in Polanco and will be a longevity ecosystem that integrates cutting -edge technology, a luxury environment and highly personalized attention.
The arrival of Grupo Lonvida arrives with two important International industry companies that support and consolidate it:
- The first is Lifenome® Biotechnology company based in New York, founded in 2016, which specializes in personalized health and well -being through AI and genomics. With presence in more than 14 countries and more than 500,000 patients treated, awarded globally by their advances in Genomic Ai® and systems biology. Its Genomics AI® platform uses biological, physiological, behavioral and environmental data to offer highly personalized evaluations. He collaborates with companies such as Pepsico, LG, Zurich Insurance, Unilever, among others.
- The second is: genetia who has developed in a joint venture between lipenome and optimal life sciences to Healtha revolutionary platform that uses artificial intelligence and more than 500 biomarkers (five times more than any other app on the market) to transform genetic and metabolic data into personalized well -being strategies.
Backed by advanced technology and led by specialists from excellence
Lonvida Group and genetia their technology partner, they are made up of a Medical and Scientist Team International, with experts from institutions such as Stanford, Mit, Duke and Weizmann Institute, as well as experienced executives such as Canyon Ranch, Uber Eats, Disney and Aeromexico.
At the head of this innovative vision Alfredo Carvajal, Co-Founder & CEO of Grupo Lonvida, a pioneer in Wellness Real Estate and leader in the integration of longevity, genomics and the health and well -being projects. Carvajal also directs genetia and Aurazen Developers, consolidating his experience in transforming access to personalized health.
He is accompanied by Jorge Santiago, Co-Founder & CFO of the group, with a solid trajectory in finance, real estate and tourism, providing strategic vision and operational solidity to this ambitious project. Within his great career, his passage through Grupo Gutsa stands out, where he was general director of Gutsa Inmobiliaria and the WTC CDMX, leading his financial restructuring and completion.
The added value for Mexico of diagnosis with AI
From DNA analysis, microbiome and methylation to metabolic biomarkers, health. It allows to detect risks before they become diseases. Thus, Lonvida Grupo creates preventive programs and customs -designed treatments. IA is transforming the field of longevity and medical advances, offering innovative tools to face aging challenges and improving health throughout life.
Allowing a foot and reduce long -term statistics and figures in the sector, since in 2023 Mexico allocated approximately 875,353 million pesos to the health sector, which represented a 2.6% of Gross Domestic Product (GDP)significantly below the 6% recommended by the World Health Organization. Mexico spent $ 1,181 per capita in health, approximately 20,702 pesos at the exchange rate of November 2023.
The resources that Lonvida Grupo will use with artificial intelligence (AI) are:
- Early diagnosis and precision medicine: The AI analyzes large volumes of medical information, such as genetic analysis, biomarkers, lifestyle and clinical data, to identify risks before they manifest. This allows appropriate interventions and adapted to the patient’s unique profile.
- Personalized medicine in action: Health and genetria algorithms allow to build specific recommendations in five key areas: diet, functional exercise, medical supplementation, skin and body care products, and even personalized suggestions for purchases in the supermarket. All supervised and validated by doctors, not by generic algorithms or social media recommendations.
- Safe selection of regenerative therapies: Thanks to the alliances of Lonvida Grupo with certified laboratories in Mexico and the US, each treatment with stem cells and exosomes is defined after a complete clinical analysis, guaranteeing that the patient is an ideal candidate in terms of safety, effectiveness and dosage. This level of customization and ethical control is not common in many aesthetic clinics or generalist applications.
- Continuous monitoring and monitoring: Connected devices allow professionals to accompany the patient remotely, evaluating in real time the evolution of key health indicators and adapting preventive or regenerative programs according to their progress.
- Promotion of healthy aging: Through the analysis of data on genetics, blood and lifestyle, its AI generates plans designed to maintain an active and functional life. The objective is clear: not only to live more years, but to live them better, with autonomy and sustained well -being.
World Class Medicine
Lonvida Grupo attracts patients from the United States and Canada, who seek advanced longevity treatments in a warm, sophisticated and technologically superior environment in Mexico. As part of Medical Tourism Association and the program Better by MastercardLonvida is also part of a global medical tourism network, guaranteeing safe processes, without friction and with multiple international payment options.
“This is how LONVIDA GROUP Redefine well -being, health and longevity in Mexico as a synonym for trust, innovation and medical excellence. ”
“Smart health, longevity without limits.”
About Lonvida:
Address: Goldsmith 38, Col. Polanco. CDMX
Ig: @lonvidalif
Related news :